Product logins

Find logins to all Clarivate products below.


Laparoscopic Devices | Market Insights | Japan | 2023

The Japanese laparoscopic device market was negatively impacted by the COVID-19 pandemic. However, the overall market for laparoscopic devices will exhibit modest growth over the forecast period, driven mainly by the continued uptake of innovative premium-priced products—including direct energy devices, powered staplers, and 4K video laparoscopes—as well as rising laparoscopic procedure volumes, attributable to the aging population, increasing prevalence of chronic diseases, and rising demand for minimally invasive procedures; however, limited reimbursement, particularly for disposable devices, will hinder revenue growth to some extent.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for laparoscopic devices in Japan from 2019 to 2031.

Related Medtech Insights Reports

Report
ENT Devices – Market Insights – Japan
The Japanese ENT device market is projected to grow at a modest pace over the forecast period, supported by a slight increase in ENT procedure volumes. This growth will be primarily driven by a…
Report
Laparoscopic Devices – Market Insights – Japan
The Japanese laparoscopic device market will expand modestly through 2035 because demand for MIS procedures will rise in line with the country’s rapidly aging population. The adoption of…
Report
Neurovascular Devices – Market Insights – Japan
The Japanese neurovascular device market will see modest growth through 2035, driven by recent technological and clinical advances, including the introduction of nextgeneration devices, expanding…
Report
Laparoscopic Devices – Market Insights – Latin America
The Latin American laparoscopic device market will experience steady moderate growth through 2035, supported by the gradual expansion of MIS volumes and selective adoption of highervalue…
Report
Dialysis Access Treatment Devices – Market Insights – Japan
The Japanese dialysis access treatment device market will decline modestly through 2035, driven by the decreased patient population requiring dialysis care due to high mortality following COVID-19…